title: Disparate Response to Methotrexate in Stem Versus Non-Stem Cells.
abstract: Methotrexate (MTX) is a commonly used chemotherapeutic agent that kills cancer cells by binding dihydrofolate reductase (DHFR) as a competitive inhibitor. Due to its non-selectivity, MTX also impairs normal (non-cancerous) cell function and causes long-term damage to healthy tissue. These consequences have been investigated extensively in bone-derived cells due to their sensitivity to the drug. While DHFR likely plays a role in normal cell response to MTX, research in this area is limited. Moreover, how MTX sensitivity differs among cell types responsible for maintaining connective tissues is unknown. The goal of this study was to investigate the role of DHFR and subsequent nucleotide synthesis in normal cell response to MTX. We also sought to compare adverse effects of MTX among normal cell types to identify sensitive populations and resistant cell sources for regenerative procedures targeting patients undergoing chemotherapy. DHFR overexpression or exogenous amino acid + nucleoside delivery rescued normal cells from adverse MTX effects. Conversely, DHFR knockdown impaired MTX-treated adipose-derived stem cell (ASC) osteogenesis. Proliferation of ASCs and bone marrow stem cells was more resistant to MTX than that of terminally differentiated osteoblasts. However, stem cells became susceptible to the drug after beginning differentiation. These results suggest that the ability of stem cells to survive and to maintain their surrounding tissues likely depends on whether they are in a "stem" state when exposed to MTX. Therapeutic strategies that delay the differentiation of stem cells until clearance of the drug may produce more favorable outcomes in the long-term health of treated tissues.
authors.affiliation: Center for Biomedical Engineering, Brown University, Providence, RI, USA.
authors.forename: Olivia S
authors.initials: OS
authors.lastname: Beane
authors.affiliation: Department of Biological Sciences, Wellesley College, Wellesley, MA, USA.
authors.forename: Louise E O
authors.initials: LE
authors.lastname: Darling
authors.affiliation: Department of Molecular Pharmacology, Physiology, & Biotechnology, Brown University, Providence, RI, USA.
authors.forename: Vera C
authors.initials: VC
authors.lastname: Fonseca
authors.affiliation: Center for Biomedical Engineering, Brown University, Providence, RI, USA. eric_darling@brown.edu.|Department of Molecular Pharmacology, Physiology, & Biotechnology, Brown University, Providence, RI, USA. eric_darling@brown.edu.|School of Engineering, Brown University, Providence, RI, USA. eric_darling@brown.edu.|Department of Orthopaedics, Brown University, Providence, RI, USA. eric_darling@brown.edu.
authors.forename: Eric M
authors.initials: EM
authors.lastname: Darling
mesh_terms: D017667:Adipocytes / Q000187:drug effects / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000187:drug effects / Q000378:metabolism; D008727:Methotrexate / Q000494:pharmacology*; D010012:Osteogenesis / Q000187:drug effects; D012038:Regeneration / Q000187:drug effects; D013234:Stem Cells / Q000187:drug effects* / Q000378:metabolism; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism
chemical_list: D013762:Tetrahydrofolate Dehydrogenase; D008727:Methotrexate
keywords: Cancer; Chemotherapy; Mesenchymal stem cell; Methotrexate; Regenerative medicine
references.citation: J Clin Invest. 1982 Aug;70(2):351-60
references.pmid: 6178756
references.citation: Exp Cell Res. 1964 Jan;33:19-28
references.pmid: 14109133
references.citation: Sci Rep. 2014;4:3819
references.pmid: 24448661
references.citation: Mol Biol Cell. 2002 Dec;13(12):4279-95
references.pmid: 12475952
references.citation: Lancet. 2012 Feb 4;379(9814):432-44
references.pmid: 22152853
references.citation: Brain Res. 2013 May 13;1510:10-21
references.pmid: 23542586
references.citation: Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):594-8
references.pmid: 1731329
references.citation: Oncologist. 1996;1(1 & 2):22-29
references.pmid: 10387965
references.citation: Ann Plast Surg. 2014 Feb;72(2):234-41
references.pmid: 23636112
references.citation: Bone. 2012 Jun;50(6):1223-33
references.pmid: 22484100
references.citation: Arthritis Res. 2002;4(4):266-73
references.pmid: 12106498
references.citation: Cancer Res. 1978 Feb;38(2):325-30
references.pmid: 637906
references.citation: J Clin Endocrinol Metab. 2003 Dec;88(12):6088-97
references.pmid: 14671215
references.citation: Br J Rheumatol. 1996 Apr;35(4):342-9
references.pmid: 8624637
references.citation: Nat Protoc. 2008;3(6):1101-8
references.pmid: 18546601
references.citation: Mol Pharmacol. 1982 May;21(3):718-22
references.pmid: 6180291
references.citation: Biomaterials. 2010 Nov;31(31):7928-36
references.pmid: 20688384
references.citation: Cell Biol Int. 2012 Sep;36(9):857-62
references.pmid: 22694597
references.citation: Biochim Biophys Acta. 1962 Apr 2;55:547-9
references.pmid: 13868897
references.citation: Spec Care Dentist. 1985 Nov-Dec;5(6):274-7
references.pmid: 3911461
references.citation: Lancet. 1991 Jan 12;337(8733):61-6
references.pmid: 1670723
references.citation: J Rheumatol. 2001 Feb;28(2):251-6
references.pmid: 11246658
references.citation: Circ Res. 2007 May 11;100(9):1249-60
references.pmid: 17495232
references.citation: Nat Protoc. 2010 Jul;5(7):1294-311
references.pmid: 20595958
references.citation: Tissue Eng. 2006 Jul;12(7):1891-901
references.pmid: 16889519
references.citation: Science. 2002 May 3;296(5569):913-6
references.pmid: 11988576
references.citation: J Clin Invest. 1985 Sep;76(3):907-12
references.pmid: 2413074
references.citation: Arthritis Rheum. 1996 Mar;39(3):489-94
references.pmid: 8607898
references.citation: Lancet. 2002 Apr 6;359(9313):1173-7
references.pmid: 11955534
references.citation: Am Fam Physician. 2008 Feb 1;77(3):311-9
references.pmid: 18297955
references.citation: Biochem Pharmacol. 1983 Jan 1;32(1):41-6
references.pmid: 6187348
references.citation: Anal Bioanal Chem. 2010 Aug;397(8):3173-8
references.pmid: 20549496
references.citation: Genome Med. 2014 Apr 29;6(4):32
references.pmid: 24944581
references.citation: Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6993-8
references.pmid: 21482784
references.citation: BMJ. 2011;343:d4013
references.pmid: 21757436
references.citation: Int J Biochem Cell Biol. 2004 May;36(5):814-25
references.pmid: 15006634
references.citation: Rheumatology (Oxford). 2002 Jul;41(7):735-40
references.pmid: 12096221
references.citation: Br J Haematol. 2004 Nov;127(3):326-34
references.pmid: 15491295
references.citation: Cancer Sci. 2010 Mar;101(3):728-34
references.pmid: 20059476
references.citation: Nature. 2008 Jun 5;453(7196):783-7
references.pmid: 18454136
references.citation: Pediatr Blood Cancer. 2014 Jan;61(1):7-10
references.pmid: 24038885
references.citation: Curr Opin Investig Drugs. 2008 Jun;9(6):591-604
references.pmid: 18516759
references.citation: J Cell Physiol. 2012 Mar;227(3):909-18
references.pmid: 21503894
references.citation: J Cell Physiol. 2006 Jan;206(1):229-37
references.pmid: 16021633
references.citation: Mol Cell Endocrinol. 2012 Sep 25;361(1-2):92-8
references.pmid: 22480543
references.citation: Cancer Res. 1983 Nov;43(11):5101-5
references.pmid: 6616448
references.citation: Cancer Res. 1976 Dec;36(12):4418-24
references.pmid: 1087180
references.citation: Int Orthop. 2010 Feb;34(1):137-42
references.pmid: 19205701
references.citation: Exp Cell Res. 2014 Oct 1;327(2):222-33
references.pmid: 24992046
references.citation: N Engl J Med. 2005 Oct 27;353(17):1784-92
references.pmid: 16251534
references.citation: J Biomech. 2015 Apr 13;48(6):1058-66
references.pmid: 25683518
references.citation: Cell Cycle. 2016 Jun 17;15(12):1531-7
references.pmid: 25483065
references.citation: Biotechnol Bioeng. 2008 Mar 1;99(4):986-95
references.pmid: 17929321
references.citation: Biochemistry. 1981 Feb 17;20(4):874-9
references.pmid: 7011378
references.citation: Eur J Clin Pharmacol. 1990;39(4):377-83
references.pmid: 2076721